All eyes on lipoprotein (a): the latest target in restenosis Gill Higgins Newsletter Article 14 February 2013 Pages: 3 - 3
Praise for terazosin and doxazosin, prazosin neglected Newsletter Article 14 February 2013 Pages: 4 - 4
New approach to treating allergic rhinitis is on trial Gill Higgins Newsletter Article 14 February 2013 Pages: 5 - 5
High dose chemotherapy could improve cancer survival rates Newsletter Article 14 February 2013 Pages: 6 - 6
Pharmacokinetics of antidepressants in the elderly needs attention Newsletter Article 14 February 2013 Pages: 7 - 7
Gene provides clues for treating motor neurone disease Newsletter Article 14 February 2013 Pages: 9 - 9
Coping with rejection: can anti-ICAM-1 antibodies help? Ian Mundell Newsletter Article 14 February 2013 Pages: 10 - 11
Anti-LFA-1 + anti-ICAM-1 better than anti-CD3 or anti-CD4 Newsletter Article 14 February 2013 Pages: 11 - 11
Qing hao: a big step forward for the treatment of malaria Newsletter Article 14 February 2013 Pages: 12 - 13
Targetting both activated and quiescent cells to beat HIV Newsletter Article 14 February 2013 Pages: 13 - 13
Alternating zidovudine/zalcitabine holds promise as an AIDS therapy Newsletter Article 14 February 2013 Pages: 14 - 14
Ambulatory BP monitoring needed to see differences between drugs Newsletter Article 14 February 2013 Pages: 15 - 15
Recommendations from the American Academy of Pediatrics Newsletter Article 14 February 2013 Pages: 17 - 17
No dramatic improvements in Alzheimer’s with piracetam Newsletter Article 14 February 2013 Pages: 17 - 17
Hydroxyzine shows promise in interstitial cystitis Newsletter Article 14 February 2013 Pages: 17 - 17
Importance of understanding opioid pharmacokinetics Newsletter Article 14 February 2013 Pages: 19 - 19